Phosphatidylserine Market

By Form;

Powder and Liquid

By End Use;

Functional Foods, Dietary Supplements & Nutraceuticals and Cosmetics & Personal Care

By Grade;

Food Grade and Pharmaceutical Grade

By Nature;

Organic and Conventional

By Source;

Plant Source [Soybean, Sunflower and Others (Cabbage Etc.)] and Animal-Derived

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Re port Timeline (2021 - 2031)
Report ID: Rn898010263 Published Date: September, 2025 Updated Date: October, 2025

Phosphatidylserine Market Overview

Phosphatidylserine Market (USD Million)

Phosphatidylserine Market was valued at USD 113.90 million in the year 2024 The size of this market is expected to increase to USD 161.34 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.1%.


Phosphatidylserine Market

*Market size in USD million

CAGR 5.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.1 %
Market Size (2024)USD 113.90 Million
Market Size (2031)USD 161.34 Million
Market ConcentrationMedium
Report Pages332
113.90
2024
161.34
2031

Major Players

  • Lonza AG
  • Enzymotec Ltd
  • Lipogen Products Ltd.
  • Doosan Corporation
  • Novastell
  • Nagase ChemteX Corporation
  • Bontac Bio-engineering (Shenzhen) Co. Ltd.
  • ECA Healthcare
  • Lipoid GmbH

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Phosphatidylserine Market

Fragmented - Highly competitive market without dominant players


The Phosphatidylserine Market is experiencing strong growth driven by rising awareness of cognitive health and the increasing adoption of nutritional supplements. Nearly 60% of demand is linked to brain health applications, reflecting its importance as a key ingredient for memory and focus. The growing inclination toward preventive healthcare and natural supplements continues to strengthen its position across industries.

Health Benefits and Applications
Phosphatidylserine is widely recognized for its role in improving cognitive performance, reducing stress, and enhancing athletic endurance. More than 40% of its usage is associated with dietary supplements aimed at boosting brain function and lowering fatigue. Additionally, its use in functional foods and beverages has expanded its reach, further supporting market adoption across different consumer groups.

Key Growth Drivers
The increasing preference for natural and plant-based supplements is a major driver, with soy-derived phosphatidylserine accounting for nearly 55% of total production. The aging population’s demand for memory-enhancing supplements, combined with younger consumers’ focus on stress management, contributes to steady growth. Sports nutrition also represents close to 20% of consumption, showcasing its versatility.

Technological Advancements
Innovations in extraction and formulation technologies have improved the efficiency and purity of phosphatidylserine production. Microencapsulation and advanced delivery systems are enhancing bioavailability, making supplements more effective. These developments are ensuring greater consumer trust and fueling consistent demand for high-quality products in the nutraceutical sector.

Future Outlook
The Phosphatidylserine Market is expected to expand steadily, supported by growing demand from dietary supplements, functional foods, and sports nutrition. Increasing consumer emphasis on preventive health, stress management, and memory support will further drive its adoption. With continued advancements in production and expanding health awareness, phosphatidylserine is set to remain a vital component in the global wellness and nutrition industry.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Form
    2. Market Snapshot, By End Use
    3. Market Snapshot, By Grade
    4. Market Snapshot, By Nature
    5. Market Snapshot, By Source
    6. Market Snapshot, By Region
  4. Phosphatidylserine Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Awareness of Cognitive Health

        2. Growing Aging Population

        3. Rising Demand for Natural and Functional Foods

      2. Restraints
        1. High Production Costs

        2. Regulatory and Compliance Challenges

        3. Limited Awareness in Emerging Markets

      3. Opportunities
        1. Growth of Personalized Nutrition and Supplements

        2. Innovations in Product Formulations

        3. Increasing Integration in Functional Foods

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Phosphatidylserine Market, By Form, 2021 - 2031 (USD Million)
      1. Powder
      2. Liquid
    2. Phosphatidylserine Market, By End Use, 2021 - 2031 (USD Million)
      1. Functional Foods
      2. Dietary Supplements & Nutraceuticals
      3. Cosmetics & Personal Care
    3. Phosphatidylserine Market, By Grade, 2021 - 2031 (USD Million)
      1. Food Grade
      2. Pharmaceutical Grade
    4. Phosphatidylserine Market, By Nature, 2021 - 2031 (USD Million)
      1. Organic
      2. Conventional
    5. Phosphatidylserine Market, By Source, 2021 - 2031 (USD Million)
      1. Plant Source
        1. Soybean
        2. Sunflower
        3. Others (Cabbage Etc.)
      2. Animal-Derived
    6. Phosphatidylserine Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Lonza AG
      2. Enzymotec Ltd
      3. Lipogen Products Ltd.
      4. Doosan Corporation
      5. Novastell
      6. Nagase ChemteX Corporation
      7. Bontac Bio-engineering (Shenzhen) Co. Ltd.
      8. ECA Healthcare
      9. Lipoid GmbH
  7. Analyst Views
  8. Future Outlook of the Market